Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-12-16 Purchase | 2022-12-19 4:22 pm | Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer | 25,000 | $0.74 | $18,500 | 40,000 (Direct) | View |
| 2022-08-17 Purchase | 2022-08-17 5:23 pm | Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer | 15,000 | $1.8 | $27,000 | 15,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-21 Option Award | 2024-03-22 08:04 am | N/A 2034-03-20 | Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer | 160,115 | $0 | 160,115 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-14 5:04 pm | N/A 2033-02-12 | Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer | 158,001 | $0 | 158,001 (Direct) | View |
| 2022-02-25 Option Award | 2022-02-25 4:42 pm | N/A 2032-02-24 | Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer | 112,470 | $0 | 112,470 (Direct) | View |
| 2021-11-01 Option Award | 2021-11-01 4:31 pm | N/A 2031-11-01 | Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer | 52,753 | $0 | 52,753 (Direct) | View |
| 2021-02-26 Option Award | 2021-03-02 5:19 pm | N/A 2031-02-25 | Millendo Therapeutics Inc. | MLND | Minai-Azary Jennifer Lynn Chief Financial Officer | 110,000 | $0 | 110,000 (Direct) | View |
Ownership | 2021-02-09 4:36 pm | N/A 2023-08-21 | Millendo Therapeutics Inc. | MLND | Minai-Azary Jennifer Lynn Chief Financial Officer | 0 | $0 | 105,340 (Direct) | View |